Literature DB >> 29223147

The unmet provision of allergy services in Hong Kong impairs capability for allergy prevention-implications for the Asia Pacific region.

Tak-Hong Lee1, Ting-Fan Leung2, Gary Wong2, Marco Ho3, Jaime Rosa Duque3, Philip Hei Li4, Chak-Sing Lau4, Wai-Fan Lam5, Adrian Wu5, Eric Chan6, Christopher Lai5, Yu-Lung Lau3.   

Abstract

INTRODUCTION: There is a high and rising prevalence of many allergic diseases in the Asia Pacific, including Hong Kong (HK), which is unmatched by a commensurate provision of clinical allergy services.
METHOD: This review highlights progress and deficiencies in allergy service and training in HK. The allergy work force was estimated from the numbers of doctors practicing allergy registered with the HK Medical Council Specialist Register in Immunology and Allergy; Paediatric Immunology and Infectious Diseases (includes allergy); Paediatrics; and Immunology (as a discipline of Pathology). The numbers of trainees were estimated from the trainee lists of the Hong Kong Colleges of Physicians, Paediatrics and Pathology. The numbers of allergy clinics were estimated from existing services in Hospital Authority public hospitals in HK.
RESULTS: In the last 3 years, two new drug allergy clinics have been established in public hospitals, and for the first time in 20 years, Hong Kong has a trainee in adult allergy. The current ratio of allergists per head of population has improved slightly from 1:1.46 million in 2014 to 1:1.17 million, but it is still low compared to many countries. There are 5-fold more paediatric allergists than adult allergists per head of population in HK. DISCUSSION: Hong Kong is not equipped to take advantage of major public health advances in allergy prevention. If the unbalance of adult to paediatric allergists remains uncorrected, continuing care for allergic children as they grow into adulthood will be an increasing problem.
CONCLUSION: Hong Kong still has an unmet need for allergy specialists and is ill equipped to exploit recently discovered public health opportunities to prevent allergy. This review provides recommendations to improve allergy service provision and training, including the creation of Centres of Excellence in allergy to drive the growth of the specialty.

Entities:  

Mesh:

Year:  2019        PMID: 29223147     DOI: 10.12932/AP-250817-0150

Source DB:  PubMed          Journal:  Asian Pac J Allergy Immunol        ISSN: 0125-877X            Impact factor:   2.310


  13 in total

1.  The Role of the Allergist in Coronavirus Disease 2019 Vaccine Allergy Safety: A Pilot Study on a "Hub-and-Spoke" Model for Population-Wide Allergy Service.

Authors:  Valerie Chiang; Chinmoy Saha; Jackie Yim; Elaine Y L Au; Andy K C Kan; Kong Siu Harris Hui; Tin Sum Li; Wing Lam Whitney Lo; Yuh Dong Hong; Jiaxi Ye; Carmen Ng; Welchie W K Ko; Carmen T K Ho; Chak Sing Lau; Jianchao Quan; Philip H Li
Journal:  Ann Allergy Asthma Immunol       Date:  2022-05-20       Impact factor: 6.248

2.  Sensitisation profile of Chinese allergic rhinitis patients and effectiveness of a joint allergy-ENT clinic.

Authors:  Harris K S Hui; Tin Sum Li; Whitney L W Lo; Andy K C Kan; Shi Yeung Ho; Winnie Y W Yeung; Jane C Y Wong; Valerie Chiang; Birgitta Y H Wong; Philip H Li
Journal:  Allergo J Int       Date:  2022-07-07

3.  Beta-lactam allergy in Chinese patients and factors predicting genuine allergy.

Authors:  Philip Hei Li; Leonard Quok Chean Siew; Iason Thomas; Timothy J Watts; Kok Loong Ue; Krzysztof Rutkowski; Chak-Sing Lau
Journal:  World Allergy Organ J       Date:  2019-09-16       Impact factor: 4.084

4.  Prevalence and Impact of Reported Drug Allergies among Rheumatology Patients.

Authors:  Shirley Chiu Wai Chan; Winnie Wan Yin Yeung; Jane Chi Yan Wong; Ernest Sing Hong Chui; Matthew Shing Him Lee; Ho Yin Chung; Tommy Tsang Cheung; Chak Sing Lau; Philip Hei Li
Journal:  Diagnostics (Basel)       Date:  2020-11-09

5.  Piperacillin-Tazobactam Allergies: An Exception to Usual Penicillin Allergy.

Authors:  Jane Cy Wong; Elaine Yl Au; Heather Hf Yeung; Chak Sing Lau; Philip Hei Li
Journal:  Allergy Asthma Immunol Res       Date:  2021-03       Impact factor: 5.764

6.  Hong Kong Anaphylaxis Consortium Consensus Statements on prescription of adrenaline autoinjectors in the acute care setting.

Authors:  Philip H Li; Gilbert T Chua; Agnes S Y Leung; Yiu-Cheung Chan; Karen K L Chan; Koon-Ho Cheung; Patrick C Y Chong; Polly P K Ho; Mike Y W Kwan; Jeffrey C H Lai; Kin-Kwai Lam; Tommy S K Lam; Ting-Fan Leung; Tin-Yan Li; Jaime S Rosa Duque; Jerome L T So; Kuang-An Wan; Henry C Y Wong; Adrian Y Y Wu; Tak-Hong Lee; Marco H K Ho; Axel Y C Siu
Journal:  Asia Pac Allergy       Date:  2021-01-06

7.  Consensus Statements on the Approach to COVID-19 Vaccine Allergy Safety in Hong Kong.

Authors:  Valerie Chiang; Agnes S Y Leung; Elaine Y L Au; Marco H K Ho; Tak Hong Lee; Adrian Y Y Wu; Gary W K Wong; Philip H Li
Journal:  Front Allergy       Date:  2021-07-14

8.  Differences in omega-5-gliadin allergy: East versus West.

Authors:  Philip Hei Li; Iason Thomas; Jane Chi-Yan Wong; Krzysztof Rutkowski; Chak-Sing Lau
Journal:  Asia Pac Allergy       Date:  2020-01-26

9.  Diagnostic procedures & practices in drug allergy/hypersensitivity: a survey of 13 Asian countries.

Authors:  Min-Moon Tang; Jie Shen Fok; Bernard Yu-Hor Thong; James Yun; Philip Hei Li; Hye-Ryun Kang; Francis Thien; Masao Yamaguchi; Michaela Lucas; Yoon-Seok Chang; Byung-Keun Kim; Mizuho Nagao; Iris Rengganis; Yi-Giien Tsai; Wen-Hung Chung; Ticha Rerkpattanapipat; Wasu Kamchaisatian; Ting Fan Leung; Joo-Yoon Ho; Luo Zhang; Amir Hamzah Abdul Latiff; Takao Fujisawa; Mariana C Castells; Pascal Demoly; Jiu Yao Wang; Ruby Pawankar
Journal:  Asia Pac Allergy       Date:  2020-10-15

10.  Experience of the first 1127 COVID-19 Vaccine Allergy Safety patients in Hong Kong - Clinical outcomes, barriers to vaccination, and urgency for reform.

Authors:  Valerie Chiang; Sabrina Wing Shan Mok; June King Chi Chan; Wai Yan Leung; Carmen Tze Kwan Ho; Elaine Y L Au; Chak Sing Lau; Tak Hong Lee; Philip Hei Li
Journal:  World Allergy Organ J       Date:  2021-12-20       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.